The biology of interferon-alpha and the clinical significance of anti-interferon antibodies.
The therapeutic indications for Interferons (IFNs) have dramatically increased in number in recent years to include many different diseases of viral, malignant, angiogenic, allergic, inflammatory and fibrotic origin. In particular, the current pandemic of hepatitis C virus infection has further stimulated the requirement for a comprehensive understanding of both the mechanism of action of IFN and the reasons for therapeutic failure. The role of anti-IFN antibodies as a cause of treatment failure has been a particularly controversial area. In this review we will outline the biology and proposed mechanisms of action of IFN-alpha (IFN-alpha) and discuss the incidence, methods of detection and clinical significance of anti-IFN antibodies.
Department of Haematology, Royal Infirmary of Edinburgh, University of Edinburgh, Scotland.
J P
JP
Hanley
G H
GH
Haydon
D000906:Antibodies / Q000032:analysis / Q000276:immunology* / Q000378:metabolism; D000918:Antibody Specificity; D000970:Antineoplastic Agents / Q000276:immunology / Q000494:pharmacology*; D000998:Antiviral Agents / Q000276:immunology / Q000494:pharmacology*; D006801:Humans; D016898:Interferon-alpha / Q000276:immunology / Q000494:pharmacology*; D017211:Treatment Failure
D000906:Antibodies; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha